We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Individualisierung der antihypertensiven Therapie bei Patienten mit Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2019).
- Authors
Schernthaner, Guntram; Saely, Christoph H.; Schernthaner, Gerit-Holger; Watschinger, Bruno; Drexel, Heinz
- Abstract
Summary: Hypertension is one of the most important comorbidities of diabetes, contributing significantly to death and leads to macrovascular and microvascular complications. When assessing the medical priorities for patients with diabetes, treating hypertension should be a primary consideration. In the present review practical approaches to hypertension in diabetes, including individualized targets for preventing specific complications are discussed according to current studies and guidelines. According to recent studies, blood pressure values of about 130/80 mm Hg are associated with the best outcome. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers are the most effective drugs for treating hypertension in diabetes. Calcium antagonists or diuretics are acceptable as second-line agents. Once the target is achieved, antihypertensive drugs should be continued. Newer antidiabetic medications such as SGLT-2-inhibitors or GLP1-receptor agonists have also antihypertensive effects.
- Subjects
ANGIOTENSIN converting enzyme; ACE inhibitors; ANGIOTENSIN receptors; BLOOD pressure; CALCIUM antagonists
- Publication
Wiener Klinische Wochenschrift, 2019, Vol 131, p124
- ISSN
0043-5325
- Publication type
Article
- DOI
10.1007/s00508-019-1460-2